🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Amlodipine 5 mg capsule

Found 42 matching trials

Efficacy and Safety of Aliskiren/Ramipril/Amlodipine Compared With Ramipril/Amlodipine and Aliskiren/Amlodipine in Patients With Metabolic Syndrome

PHASE4

This proof of concept study is designed to evaluate the efficacy and safety...

Status

Terminated

Location

Addenbrookes Hospital

Start Date

2008-03

Trial ID

NCT00542269

Treatments Being Tested

Amlodipine Aliskiren Ramipril

Efficacy and Safety of SPA100 (Fixed-dose Combination of Aliskiren/Amlodipine) in Patients With Essential Hypertension

PHASE3

The purpose of the study was to evaluate the efficacy (blood pressure lower...

Status

Completed

Location

Investigative Site

Start Date

2010-10

Trial ID

NCT01237223

Treatments Being Tested

Aliskiren/Amlodipine 150/2.5 mg Aliskiren/amlodipine 150/5 mg Aliskiren 150 mg Amlodipine 2.5 mg Placebo of Aliskiren Placebo of Amlodipine Placebo of Aliskiren/amlodipine 150/2.5 mg Placebo of Aliskiren/amlodipine 150/5 mg

Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 as Compared to Amlodipine/Valsartan 5/40 or to Amlodipine 5 mg Monotherapy in Patients 65 Years of Age and Older With Essential Hypertension

PHASE3

To characterize the safety, tolerability, and efficacy profile of amlodipin...

Status

Completed

Location

Novartis Investigative site

Start Date

2008-05

Trial ID

NCT00699192

Treatments Being Tested

Amlodipine 5 mg Valsartan 80 mg Valsartan 40 mg Placebo

Efficacy and Safety of Valsartan/Amlodipine in Patients With Mild to Moderate Essential Hypertension

PHASE3

This study assessed the efficacy and safety of the valsartan/amlodipine 160...

Status

Completed

Location

Investigative site in Romainia

Start Date

2009-09

Trial ID

NCT01001572

Treatments Being Tested

Valsartan/amlodipine 160/5 mg Valsartan 160 mg Placebo

Efficacy and Safety of the Combination of Aliskiren (300 mg) and Amlodipine (10 mg) Compared to Amlodipine (10 mg) Monotherapy in Patients With Moderate to Severe Hypertension

PHASE3

This study will compare the blood pressure (BP) lowering effect of the comb...

Status

Completed

Location

Investigative Site

Start Date

2009-01

Trial ID

NCT00841672

Treatments Being Tested

Aliskiren/amlodipine 300/10 mg tablet Amlodipine 10 mg capsule

Comparison of Aliskiren and Amlodipine on Insulin Resistance and Endothelial Dysfunction in Patients With Hypertension and Metabolic Syndrome

PHASE2

The purpose of this study was to determine the effects of Aliskiren on insu...

Status

Completed

Location

Novartis Investigative Site

Start Date

2007-10

Trial ID

NCT00417170

Treatments Being Tested

Aliskiren Amlodipine Placebo Aliskiren Placebo Amlodipine

Efficacy/Safety of Valsartan Plus Amlodipine and Valsartan Alone in Patients With Hypertension

PHASE3

This study evaluated the safety and efficacy of the fixed combination of va...

Status

Completed

Location

Beijing ChaoYang Hospital, Affiliate of Capital University of Medical Sciences

Start Date

2007-01

Trial ID

NCT00413413

Treatments Being Tested

Valsartan/amlodipine 80/5 mg Valsartan 80 mg Valsartan 160 mg

Effect of Antihypertensive Agents on Diastolic Function in Patients With Sleep Apnea

PHASE3

The investigators investigated diastolic function among patients with obstr...

Status

Completed

Location

Hospital de Clinicas de Porto Alegre

Start Date

2014-12-07

Trial ID

NCT02896621

Treatments Being Tested

Chlorthalidone plus amiloride Amlodipine

Aliskiren Study of Safety and Efficacy in Senior Hypertensives

PHASE4

This study is designed to compare the blood pressure lowering efficacy of a...

Status

Withdrawn

Location

Multiple Locations

Start Date

2015-05

Trial ID

NCT01922141

Treatments Being Tested

Aliskiren Amlodipine Ramipril Hydrochlorothiazide

Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Amlodipine in Essential Hypertension

PHASE3

Evaluate the efficacy (blood pressure lowering effect) and safety of aliski...

Status

Completed

Location

Investigative Site

Start Date

2008-09

Trial ID

NCT00739973

Treatments Being Tested

Placebo Aliskiren 150 mg tablet Aliskiren 300 mg tablet Amlodipine 5 mg capsule Amlodipine 10 mg capsule Aliskiren/amlodipine 150/5 mg tablet Aliskiren/amlodipine 150/10 mg tablet Aliskiren/amlodipine 300/5 mg tablet Aliskiren/amlodipine 300/10 mg tablet

Previous Next